EP2712648A1 - Cathéter avec extension de cloison articulable - Google Patents

Cathéter avec extension de cloison articulable Download PDF

Info

Publication number
EP2712648A1
EP2712648A1 EP13199397.4A EP13199397A EP2712648A1 EP 2712648 A1 EP2712648 A1 EP 2712648A1 EP 13199397 A EP13199397 A EP 13199397A EP 2712648 A1 EP2712648 A1 EP 2712648A1
Authority
EP
European Patent Office
Prior art keywords
septum
catheter
lumens
extension
septum extension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP13199397.4A
Other languages
German (de)
English (en)
Other versions
EP2712648B1 (fr
Inventor
Manish Deshpande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Covidien LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Covidien LP filed Critical Covidien LP
Publication of EP2712648A1 publication Critical patent/EP2712648A1/fr
Application granted granted Critical
Publication of EP2712648B1 publication Critical patent/EP2712648B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A61M25/0075—Valve means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3659—Cannulae pertaining to extracorporeal circulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3621—Extra-corporeal blood circuits
    • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
    • A61M1/3659—Cannulae pertaining to extracorporeal circulation
    • A61M1/3661—Cannulae pertaining to extracorporeal circulation for haemodialysis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026—Multi-lumen catheters with stationary elements
    • A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/285—Catheters therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026—Multi-lumen catheters with stationary elements
    • A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
    • A61M2025/0031—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves characterized by lumina for withdrawing or delivering, i.e. used for extracorporeal circuit treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
    • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
    • A61M25/0026—Multi-lumen catheters with stationary elements
    • A61M2025/0037—Multi-lumen catheters with stationary elements characterized by lumina being arranged side-by-side
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M2025/0073—Tip designed for influencing the flow or the flow velocity of the fluid, e.g. inserts for twisted or vortex flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0413—Blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
    • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
    • A61M25/008—Strength or flexibility characteristics of the catheter tip

Definitions

  • the present disclosure relates generally to medical catheters, and more particularly to a multiple lumen catheter having an articulable septum extension.
  • Catheters are flexible medical instruments for use in the introduction and withdrawal of fluids to and from body cavities, ducts and vessels. Catheters are used for many different applications within the human body including the administration of liquid therapeutic agents and the removal of bodily fluids for testing, monitoring, or disposal. Catheters have a particular application in hemodialysis procedures, in which blood is withdrawn from a blood vessel, directed to a hemodialysis unit for dialysis or purification, and subsequently returned to the blood vessel.
  • dialysis catheters define at least two lumens including a venous lumen and an arterial lumen.
  • the arterial lumen withdraws blood from the patient and delivers the blood to a dialyzer.
  • the venous lumen receives purified blood from the dialyzer and returns the blood to the patient.
  • the venous and arterial lumens may include distal openings adjacent the tip of the catheter.
  • the venous and arterial lumens may also include side openings which provide redundant or alternate flow paths to and from the arterial and venous lumens.
  • the efficiency of a hemodialysis procedure may be reduced by recirculation of blood flow at a distal end of the catheter.
  • Recirculation occurs when dialyzed blood exiting the venous lumen is drawn directly back into the arterial lumen of the catheter.
  • some catheter devices stagger the openings of the catheter lumens such that the opening of the venous lumen is disposed distally beyond the opening of the arterial lumen.
  • These catheter devices also suffer from various additional drawbacks.
  • the staggered openings of the venous lumen and arterial lumen render the catheter less suitable for reversing fluid flow through the catheter. Reversibility of fluid flow through the catheter may be used to remove the formation of thrombus within an opening of the catheter.
  • the staggered openings may disadvantageously indirectly result in a higher likelihood of flow occlusion within the catheter.
  • the present disclosure is directed to a catheter having an elongated tubular body including a first wall and second wall defining first and second lumens, respectively.
  • the elongated tubular body defines a longitudinal axis.
  • Each wall extends to a distal end and defines a distal opening.
  • One of the first and second lumens permits fluid inflow at the distal opening of the respective one of the first and second lumens and the other of the first and second lumens permits fluid outflow at the distal opening of the respective one of the first and second lumens.
  • the first and second walls may each include one or more side openings disposed proximal of the distal end.
  • the first and second lumens are separated by a septum that extends to the distal end of the catheter.
  • the septum includes a septum extension extending distally from the septum.
  • the septum extension is adapted to articulate about a distal end of the septum at an acute angle relative to the longitudinal axis.
  • the septum and the septum extension may be integrally formed.
  • the septum extension is cantilevered to the septum.
  • the septum extension is adapted to articulate relative to the septum in response to fluid flow to and from the distal opening of the first and second lumens.
  • the septum extension is dimensioned to partially obstruct fluid flow into the catheter through one of the distal openings upon the articulation of the septum extension.
  • the septum extension includes a base and a body.
  • the base defines two or more recesses that permit the body of the septum extension to articulate towards one of the first and second lumens while fluid is flowing to and from the distal openings of the first and second lumens.
  • the septum extension is articulable in a first direction towards one of the first and second lumens.
  • the septum extension is articulable in a second direction towards the other of the first and second lumens when fluid flow is reversed.
  • the septum extension may include a first thickness and a second thickness different from the first thickness.
  • One of the first and second thicknesses facilitates the movement of the septum extension relative to the septum.
  • the septum extension includes one or more recesses that permit the septum extension to articulate relative to the septum.
  • the septum extension includes structure to further enhance movement of the septum extension.
  • the septum extension may include a protuberant distal end.
  • the protuberant distal end may include one or more of a curvilinear configuration, a spherical configuration, or a polygonal configuration.
  • the septum defines a plane.
  • the first and second wall are substantially symmetrically disposed about the plane.
  • the present disclosure is directed to a method of limiting undesirable recirculation in a catheter.
  • the method involves providing a catheter having a tubular body defining a pair of side openings, an arterial lumen, and a venous lumen, the arterial lumen and the venous lumen being separated by a septum, the septum including an articulable septum extension.
  • the method includes the step of articulating the septum extension relative to the septum to restrict fluid flow into the distal opening of the arterial lumen.
  • the exemplary embodiments of the catheter and methods of use disclosed are discussed in terms of medical catheters for the administration of fluids (withdrawal, introduction, etc.) to/from the body of a subject and more particularly, in terms of a catheter including a catheter tip that limits undesirable recirculation during use to facilitate unobstructed fluid flow to/from the catheter.
  • the catheter is advantageously configured to facilitate reversible fluid flow between lumens thereof.
  • the present disclosure may be employed with a range of catheters, such as, for example, hemodialysis, peritoneal, infusion, PICC, CVC, and port for a variety of catheter applications including surgical, diagnostic and related treatments of diseases and body ailments of a subject.
  • proximal will refer to the portion of a structure that is closer to a practitioner, while the term “distal” will refer to the portion that is further from the practitioner.
  • distal will refer to the portion that is further from the practitioner.
  • the term “practitioner” refers to a doctor, nurse or other care provider and may include support personnel.
  • subject refers to a human patient or other animal.
  • FIG. 1 the present disclosure, according to one embodiment, is directed to a catheter 100.
  • Catheter 100 has an elongated tubular body 102 defining a longitudinal axis "L" Body 102 has a cylindrical outer surface 103 that may be variously dimensioned and attachable to other medical devices. As appreciated, outer surface 103 may have various cross-sectional configurations, such as, for example, oval, rectangular, elliptical, and polygonal.
  • Elongated tubular body 102 includes a first wall 104 and second wall 106.
  • First wall 104 defines a first lumen 104a and second wall 106 defines a second lumen 106a.
  • the lumens 104a, 106a extend along a length or a portion of the length of the tubular body 102 to distal openings 118.
  • first and second lumens 104a, 106a and distal openings 118 are illustrated to have a D-shaped configuration, any other suitable configuration is envisioned, such as oval, rectangular, elliptical, and polygonal.
  • Lumens 104a, 106a may be uniformly dimensioned or include alternative dimensional cross sections within body 102, such as, narrow and broad portions, converging surfaces, or undulating surfaces, according to the particular flow indications and/or flow rate requirements.
  • first lumen 104a and second lumen 106a may extend to alternative lengths.
  • body 102 may include any number of lumens such as a triple lumen configuration.
  • Each wall 104, 106 extends from a proximal end 107 to a distal end 108 and may define one or more side openings 110 disposed proximal of distal end 108. As illustrated in FIG. 1 , each wall 104, 106 may include extensions that extend beyond the first and second lumens 104a, 106a. In embodiments, each wall 104, 106 may extend only to the distal openings 118 of one of the respective first and second lumens 104a, 106a. The one or more side openings 110 may be disposed on any suitable portion of elongated tubular body 102.
  • the one or more side openings 110 may be disposed in the outer surface 103 and may be positioned anywhere along the circumference of the body 102 proximal to the distal end 108 of the tubular body 102.
  • the side openings 110 may be any suitable size and/or have any suitable geometry.
  • the side openings 110 may also have contoured edges formed or may be otherwise smoothed to minimize the likelihood of thrombus formation.
  • first wall 104 may include a first side opening 110a in fluid communication with first lumen 104a and second wall 106 may include a second side opening 110b in fluid communication with second lumen 106a.
  • first lumen 104a or the second lumen 106a may function as a venous lumen or an arterial lumen of the catheter 100.
  • the arterial lumen is used to withdraw blood from the patient (e.g., via suction) and direct the blood to a dialyzer, while the venous lumen is used to return dialyzed blood to the patient from the dialyzer.
  • the catheter 100 may be configured for reversible flow to wash away thrombus or other undesirable debris which may build up on the catheter 100.
  • catheter configured such that either lumen 104a and 106a may function as the arterial or venous lumen with no appreciable change to the flow characteristics of the catheter.
  • the venous and arterial lumens are separated by a septum 112 which defines a plane "P.” Septum 112 is medially disposed, along a substantial portion of the longitudinal length of body 102, between first lumen 104a and second lumen 106a.
  • First and second walls 104, 106 may be substantially symmetrically disposed about plane "P."
  • the arterial lumen permits fluid inflow at distal end 108 adjacent respective first or second wall 104, 106.
  • the venous lumen permits fluid outflow at distal end 108 adjacent the other respective first or second wall 104, 106.
  • Septum 112 includes a septum extension 114 extending distally from septum 112.
  • Septum extension 114 is movable relative to septum 112 in response to fluid flow through first and second lumens 104a, 106a in order to limit undesirable recirculation of fluid "F" through the arterial lumen of the catheter 100. Movement of the septum extension 114 occurs in response to fluid flow through the catheter 100. More specifically, a pressure difference is created between opposing surfaces of septum extension 114 as fluid flows into and out of distal openings 118.
  • This pressure differential induces a net force from the fluid outflow side (i.e., venous lumen) to the fluid inflow side (i.e., arterial lumen), causing septum extension 114 to articulate, pivot, or deflect towards the fluid inflow side.
  • the fluid outflow side i.e., venous lumen
  • the fluid inflow side i.e., arterial lumen
  • septum extension 114 is movable towards the arterial lumen in response to fluid flow through catheter 100.
  • septum extension 114 will articulate towards first lumen 104a as shown in FIG. 2 .
  • septum extension 114 will articulate about longitudinal axis "L” toward second lumen 106a and second wall 106 in the same manner as described above with respect to the opposite fluid flow direction.
  • Septum extension 114 may be cantilevered to septum 112 to form a hinge relative to septum 112 and includes a base 114a and a septum body 114b.
  • base 114a of septum extension 114 includes a first reduced thickness to facilitate articulation of body 114b about base 114a in response to a predetermined fluid flow rate through catheter 100 sufficient to achieve the pressure differential discussed above.
  • the reduced thickness of base 114a may be effected by providing one or more recesses 116 on one or both sides of septum extension 114 that permit septum extension 114 to bend, deflect or articulate relative to septum 112.
  • base 114a may be formed of a different material than septum body 114b to facilitate articulation of septum body 114b in relation to septum 112 about base 114a.
  • the material of base 114a may be any suitable flexible material. The materials of the presently disclosed catheters will be discussed in greater detail below.
  • Two or more recesses 116 may be symmetrically disposed relative to each other to define base 114a of septum extension 114 and to permit septum body 114b of septum extension 114 to articulate while fluid is flowing through first and second lumens 104a, 106a.
  • septum extension 114 may be articulable about a distal end of septum 112 at an acute angle relative to longitudinal axis "L.”
  • septum 112 and septum extension 114 may be integrally formed or separately connected.
  • septum extension 114 Movement of septum extension 114 towards the arterial or inflow lumen increases inflow resistance at the distal end 108 of catheter 100 to limit undesirable recirculation.
  • distal opening 118 of the arterial lumen is at least partially obstructed by septum extension 114. This obstruction restricts fluid inflow through distal opening 118.
  • fluid outflow from distal opening 118 of the venous lumen is unrestricted.
  • the primary fluid flow into the arterial lumen will be through the side opening 110 and the primary fluid from the venous lumen will be from the distal opening 118 of the venous lumen. Since the distal openings 118 and side openings 110 are spaced, the likelihood for recirculation to occur is minimized.
  • catheter 200 is similar to catheter 100 and is described herein only to the extent necessary to describe the differences in construction and operation.
  • Catheter 200 has an elongated tubular body 102 that includes first wall 104 and second wall 106.
  • First wall 104 defines a first lumen 104a and second wall 106 defines a second lumen 106a.
  • the lumens 104a, 106a extend along a length or a portion of the length of the tubular body 102 to distal openings 118.
  • Either the first lumen 104a or the second lumen 106a may function as a venous lumen or an arterial lumen as discussed above with regard to catheter 100.
  • the venous and arterial lumens are separated by a septum 212 that is medially disposed, along a substantial portion of the longitudinal length of body 102, between first lumen 104a and second lumen 106a.
  • Septum 212 includes a septum extension 214 extending distally from septum 112.
  • Septum extension 214 includes a base 214a and a septum body 214b.
  • a portion of septum body 214b has enlarged dimensions to further enhance pivotal or articulating movement of the septum extension 214.
  • septum body 214b includes a protuberant distal end 216 that further enhances pivotal or articulating movement of the septum body 214b relative to base 214a in response to a predetermined fluid flow rate through catheter 200 sufficient to achieve the pressure differential discussed above with respect to catheter 100.
  • protuberant distal end 216 may have any suitable shape sufficient to enhance pivotal or articulating movement of the septum body 214b.
  • protuberant distal end 216 may have a curvilinear configuration, a spherical configuration, or a polygonal configuration.
  • any of the presently disclosed surfaces and/or components of the presently disclosed catheters may be planar or non-planar, such as, for example, arcuate, undulating, or textured.
  • the components of the presently disclosed catheters are fabricated from materials suitable for medical applications, such as, for example, polymerics or metals, such as stainless steel, depending on the particular catheter application and/or preference of a practitioner.
  • materials suitable for medical applications such as, for example, polymerics or metals, such as stainless steel, depending on the particular catheter application and/or preference of a practitioner.
  • Semi-rigid and rigid polymerics are contemplated for fabrication, as well as resilient materials, such as molded medical grade polypropylene or polyurethane.
  • resilient materials such as molded medical grade polypropylene or polyurethane.

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • External Artificial Organs (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EP13199397.4A 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable Active EP2712648B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/248,658 US8636682B2 (en) 2011-09-29 2011-09-29 Catheter with articulable septum extension
EP12183701.7A EP2574363B1 (fr) 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
EP12183701.7A Division-Into EP2574363B1 (fr) 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable
EP12183701.7A Division EP2574363B1 (fr) 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable

Publications (2)

Publication Number Publication Date
EP2712648A1 true EP2712648A1 (fr) 2014-04-02
EP2712648B1 EP2712648B1 (fr) 2015-03-25

Family

ID=46970004

Family Applications (2)

Application Number Title Priority Date Filing Date
EP12183701.7A Active EP2574363B1 (fr) 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable
EP13199397.4A Active EP2712648B1 (fr) 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP12183701.7A Active EP2574363B1 (fr) 2011-09-29 2012-09-10 Cathéter avec extension de cloison articulable

Country Status (9)

Country Link
US (2) US8636682B2 (fr)
EP (2) EP2574363B1 (fr)
JP (1) JP2013075162A (fr)
CN (1) CN103028188B (fr)
AU (1) AU2012216812B2 (fr)
BR (1) BR102012024788A2 (fr)
CA (1) CA2789300A1 (fr)
ES (2) ES2536968T3 (fr)
MX (1) MX2012010875A (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103619372A (zh) 2011-03-23 2014-03-05 纳科斯达格医药股份有限公司 腹膜透析系统、装置和方法
US9861733B2 (en) 2012-03-23 2018-01-09 Nxstage Medical Inc. Peritoneal dialysis systems, devices, and methods
EP2741806B1 (fr) 2011-08-11 2018-11-07 Medical Components, Inc. Appareil pour la dialyse de sang
US8636682B2 (en) 2011-09-29 2014-01-28 Covidien Lp Catheter with articulable septum extension
CA2871329C (fr) * 2012-04-23 2019-05-28 Aegis Medical Technologies, Llc Catheter a lumieres multiples
US10155100B2 (en) * 2014-03-27 2018-12-18 Covidien Lp Catheter positioning
CN104274874B (zh) * 2014-10-28 2016-11-16 郑州迪奥医学技术有限公司 防堵塞血透导管
CN106606812A (zh) * 2015-10-21 2017-05-03 俞晓立 一种可置入人体血管和体腔内的导管
US20170215897A1 (en) * 2016-01-28 2017-08-03 Gyrus Acmi, Inc., D.B.A. Olympus Surgical Technologies America Apparatus for Stone Fragments Removal
USD905853S1 (en) 2018-02-27 2020-12-22 Medical Components, Inc. Catheter tip
US11207454B2 (en) 2018-02-28 2021-12-28 Nxstage Medical, Inc. Fluid preparation and treatment devices methods and systems
KR102341692B1 (ko) * 2019-05-21 2021-12-21 성균관대학교산학협력단 카테터
CN111494783A (zh) * 2020-06-01 2020-08-07 河南曙光健士医疗器械集团股份有限公司 双腔导管及其制成的中心静脉导管
USD984880S1 (en) 2020-11-06 2023-05-02 Medical Components, Inc. Clamp with indicator

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096334A1 (fr) * 2003-03-28 2004-11-11 Sherwood Services Ag Catheter a extremite resistant a l'occlusion
US20060253063A1 (en) * 2005-05-09 2006-11-09 Medical Components, Inc. Security tip for vascular catheter and method of using same
US20090216174A1 (en) * 2008-02-21 2009-08-27 Mahase Nardeo Double lumen dialysis catheter with closeable arterial distal port
EP2168625A1 (fr) * 2008-09-26 2010-03-31 Tyco Healthcare Group LP Cathéter d'hémodialyse à valve

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5569182A (en) 1990-01-08 1996-10-29 The Curators Of The University Of Missouri Clot resistant multiple lumen catheter and method
US5156600A (en) * 1990-10-10 1992-10-20 Strato Medical Corporation Bidirectional check valve catheter
US5112301A (en) * 1991-06-19 1992-05-12 Strato Medical Corporation Bidirectional check valve catheter
US5165450A (en) * 1991-12-23 1992-11-24 Texaco Inc. Means for separating a fluid stream into two separate streams
US5224938A (en) * 1992-03-18 1993-07-06 Strato Medical Corporation Valved catheter
US6056001A (en) * 1994-03-14 2000-05-02 Texaco Inc. Methods for positively assuring the equal distribution of liquid and vapor at piping junctions in two phase flow by intermittent flow interruption
US5807349A (en) * 1997-03-10 1998-09-15 United States Surgical Corporation Catheter having valve mechanism
US5928203A (en) 1997-10-01 1999-07-27 Boston Scientific Corporation Medical fluid infusion and aspiration
US6004395A (en) * 1997-12-19 1999-12-21 Xerox Coporation Paper handling flap valve array system
US6098661A (en) * 1997-12-19 2000-08-08 Xerox Corporation Unstable flap valve for fluid flow control
US6293958B1 (en) * 1998-07-27 2001-09-25 Acist Medical Systems, Inc. Catheter having flow diffusing tip
FR2790300B1 (fr) * 1999-02-26 2001-04-27 Mark Iv Systemes Moteurs Sa Ensemble a clapet et dispositif de circulation et de distribution de fluide comprenant un tel ensemble
US20020156430A1 (en) 2001-04-19 2002-10-24 Haarala Brett T. Catheter slit valves
US7090654B2 (en) 2003-03-28 2006-08-15 Sherwood Services Ag Catheter with occlusion resistant tip
US7776005B2 (en) 2003-03-28 2010-08-17 Covidien Ag Triple lumen catheter with occlusion resistant tip
US7322953B2 (en) 2003-08-04 2008-01-29 Covidien Ag Catheter device
EP1720595B1 (fr) * 2004-03-03 2011-05-11 C.R.Bard, Inc. Catheter a extremite en forme de boucle
US20070225678A1 (en) 2006-03-23 2007-09-27 Cook Vascular Incorporated Two-way valved catheter
US20080097350A1 (en) * 2006-07-06 2008-04-24 Bell Barbara A Medical devices
US20090054874A1 (en) 2007-08-23 2009-02-26 C. R. Bard, Inc. Multi-lumen catheter including a lumen having a variable cross sectional area
US8337451B2 (en) * 2007-10-19 2012-12-25 Angio Dynamics, Inc. Recirculation minimizing catheter
JP2009273609A (ja) 2008-05-14 2009-11-26 Nippon Sherwood Medical Industries Ltd 弁付きカテーテル
US20110263976A1 (en) * 2008-07-18 2011-10-27 Hassan Ali H Methods and Devices for Endovascular Introduction of an Agent
PT2228090E (pt) 2009-03-12 2012-02-20 Joline Gmbh & Co Kg Cateter de duplo lúmen
US8636682B2 (en) 2011-09-29 2014-01-28 Covidien Lp Catheter with articulable septum extension

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004096334A1 (fr) * 2003-03-28 2004-11-11 Sherwood Services Ag Catheter a extremite resistant a l'occlusion
US20060253063A1 (en) * 2005-05-09 2006-11-09 Medical Components, Inc. Security tip for vascular catheter and method of using same
US20090216174A1 (en) * 2008-02-21 2009-08-27 Mahase Nardeo Double lumen dialysis catheter with closeable arterial distal port
EP2168625A1 (fr) * 2008-09-26 2010-03-31 Tyco Healthcare Group LP Cathéter d'hémodialyse à valve

Also Published As

Publication number Publication date
AU2012216812B2 (en) 2013-05-23
US8636682B2 (en) 2014-01-28
US20130085437A1 (en) 2013-04-04
BR102012024788A2 (pt) 2013-10-29
CA2789300A1 (fr) 2013-03-29
EP2574363B1 (fr) 2014-03-26
ES2536968T3 (es) 2015-06-01
CN103028188B (zh) 2014-08-13
AU2012216812A1 (en) 2013-04-18
EP2574363A1 (fr) 2013-04-03
MX2012010875A (es) 2013-03-28
US20140081199A1 (en) 2014-03-20
JP2013075162A (ja) 2013-04-25
CN103028188A (zh) 2013-04-10
ES2471949T3 (es) 2014-06-27
EP2712648B1 (fr) 2015-03-25
US9056183B2 (en) 2015-06-16

Similar Documents

Publication Publication Date Title
US9056183B2 (en) Catheter with articulable septum extension
CA2519388C (fr) Catheter a triple lumiere a extremite resistant a l'occlusion
EP1641511B1 (fr) Catheter equipe d'une extremite qui resiste aux occlusions
US7322953B2 (en) Catheter device
EP2574364B1 (fr) Cathéter avec surfaces coniques
US7090654B2 (en) Catheter with occlusion resistant tip
CA2520572C (fr) Catheter a extremite resistant a l'occlusion
JP2008503274A5 (fr)
NZ543012A (en) Catheter with occlusion resistant tip
ZA200508692B (en) Catheter with occlusion resistant tip

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AC Divisional application: reference to earlier application

Ref document number: 2574363

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

17P Request for examination filed

Effective date: 20140822

RBV Designated contracting states (corrected)

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61M 25/00 20060101AFI20140916BHEP

Ipc: A61M 1/36 20060101ALI20140916BHEP

Ipc: A61M 1/28 20060101ALN20140916BHEP

INTG Intention to grant announced

Effective date: 20141015

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AC Divisional application: reference to earlier application

Ref document number: 2574363

Country of ref document: EP

Kind code of ref document: P

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602012006234

Country of ref document: DE

Effective date: 20150507

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 717507

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150515

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2536968

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20150601

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 717507

Country of ref document: AT

Kind code of ref document: T

Effective date: 20150325

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150626

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150727

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150725

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602012006234

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20160105

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: LU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150910

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

REG Reference to a national code

Ref country code: IE

Ref legal event code: MM4A

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150910

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150930

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20150930

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 5

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20160910

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150625

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20120910

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160910

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 6

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

Ref country code: MK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 7

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20150325

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20181001

Year of fee payment: 7

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20200824

Year of fee payment: 9

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20210127

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20190911

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20210819

Year of fee payment: 10

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20210910

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20220930

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20230822

Year of fee payment: 12